Development of a Drop-In Purification Step for Removal of Aggregates from an Antibody Therapeutic
Mammalian
Development of a Modified Purification Process for a Monoclonal Antibody Therapeutic-Yield Improvement
Application of Definitive Screening Design (DSD) to the icIEF Assay Development of Antibodies and Therapeutic Proteins
Strategies of CHO Cell Line Development and Toolbox Implementation for Improving Cell Line Productivity and Stability
Identification and Risk Mitigation of a Critical Process Parameter during Antibody Process Scale-up
Leveraging Innovation to Achieve Manufacturing Excellence Across Mammalian and Microbial Biologics Processes